Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia
- Conditions
- Neurocognitive DisordersSchizophrenia
- Interventions
- Behavioral: GMT
- Registration Number
- NCT03048695
- Lead Sponsor
- Sykehuset Innlandet HF
- Brief Summary
About 85% of patients with schizophrenia have cognitive impairments, executive functions being particularly affected. Executive dysfunction, and cognitive deficits in general, are important predictors of functional outcomes, including social problem solving, activities of daily living, life satisfaction, and the ability to return to work or school.The main objective of the current study is to examine the efficacy of group-based Goal Management Training (GMT) for patients with broad schizophrenia spectrum disorders or high risk individuals with executive deficits. The short term goals are to investigate whether GMT can improve participants' ability to organize and achieve goals in everyday life in addition to improving aspects of emotional health. A long-term goal would be to establish an evidence base for nonpharmacological interventions for patients with broad schizophrenia spectrum disorders or high risk for schizophrenia. Main research questions: (1) Does a RCT with GMT delivered to patients with broad schizophrenia spectrum disorders or high risk for schizophrenia result in improved executive functioning, measured by self-reported and/or objective measures of executive functions? (2) Does GMT result in improved goal attainment in everyday life, social- and real world functioning? (3) Does GMT have a positive impact on the patients' emotional health? (4) Are there specific characteristics in patients with broad schizophrenia spectrum disorders or high risk for schizophrenia that are associated with better treatment benefit from GMT?
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 83
- Being consecutively referred to treatment for a DSM-IV diagnosis of broad schizophrenia spectrum psychosis (schizophrenia, schizophreniform disorder and schizoaffective disorder) or high risk for psychosis or being treated for psychotic disorder for less than 5 years.
- Reporting executive problems through (a) structured interview, or (b) self-report, i.e. BRIEF scale T-score < 55.
- Reported ongoing alcohol or substance abuse.
- Premorbid neurological disease or insult and/or comorbid neurological disease. ° Severe cognitive problems interfering with the capacity to participate.
- IQ below 70.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Goal Management Training GMT Cognitive rehabilitation
- Primary Outcome Measures
Name Time Method Conners Continuous Performance Test III Baseline, immediately post-intervention and 6 months follow-up Assessing change
Behavior Rating Inventory for Executive Functions Baseline, immediately post-intervention and 6 months follow-up Assessing change
Positive and Negative Syndrome Scale Baseline, immediately post-intervention and 6 months follow-up Assessing change
- Secondary Outcome Measures
Name Time Method Dysexecutive Questionnaire (self-and informant) Baseline, immediately post-intervention and 6 months follow-up Assessing change
Global Assessment of Functioning-Split Version Baseline, immediately post-intervention and 6 months follow-up Assessing change
The Hotel Task Baseline, immediately post-intervention and 6 months follow-up Assessing change
Delis Kaplan Executive Function System (D-KEFS) subtests Baseline, immediately post-intervention and 6 months follow-up Assessing change
Digit span and Letter-number sequencing Baseline, immediately post-intervention and 6 months follow-up Assessing change
Iowa Gambling Task Baseline, immediately post-intervention and 6 months follow-up Assessing change
Goal Attainment Scaling Baseline, immediately post-intervention and 6 months follow-up Assessing change
Everyday Functioning from NORMENT Long time follow up questionnaires Baseline, immediately post-intervention and 6 months follow-up Assessing change
General Perceived Self-Efficacy Scale Baseline, immediately post-intervention and 6 months follow-up Assessing change
The Perceived Quality of Life Scale Baseline, immediately post-intervention and 6 months follow-up Assessing change
Rosenberg self-esteem scale Baseline, immediately post-intervention and 6 months follow-up Assessing change
Cognitive Failures Questionnaire Baseline, immediately post-intervention and 6 months follow-up Assessing change
Social Functioning Scale Baseline, immediately post-intervention and 6 months follow-up Assessing change
Hopkins Symptom Checklist 10 Baseline, immediately post-intervention and 6 months follow-up Assessing change
Trial Locations
- Locations (1)
Sykehuset Innlandet Reinsvoll
🇳🇴Reinsvoll, Norway